NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Clinical Trial Not Allowed) | PAR 23 286

FAQs: NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00)

What is the NCI Pathway to Independence Award (K99/R00)?

The NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00) is an NIH grant from the National Cancer Institute (NCI) designed to help promising postdoctoral researchers transition from mentored postdoctoral training into independent faculty careers. It is structured specifically to support the move from a postdoc environment into an independent, tenure-track (or equivalent) research position.

What is the main purpose of this award?

The central goal is to strengthen the pipeline of NCI-supported investigators by providing a clear, structured bridge across a common career bottleneck: the transition from postdoctoral training to research independence. The award is intended for early-stage postdocs who are already strongly prepared and do not need an extended additional training period to become competitive as independent investigators.

How does the K99/R00 structure work?

This mechanism is built around a transition between two phases: (1) a mentored postdoctoral phase (the K99 phase) focused on targeted career development and research activities, and (2) an independent phase (the R00 phase) that provides research support once the candidate moves into an independent position, helping launch an autonomous lab or research program.

What happens during the mentored (K99) phase?

In the K99 phase, the candidate remains in a mentored postdoctoral environment and proposes focused career development and research activities intended to finalize training, build momentum, and position the candidate for an independent faculty appointment.

What happens during the independent (R00) phase?

In the R00 phase, the award provides research support to help the candidate establish an independent research program after securing an independent position (for example, a tenure-track or equivalent faculty role). The intent is to provide continuity of support as the candidate becomes an independent investigator.

Who is this opportunity meant for?

It is aimed at early-stage postdoctoral researchers who already have strong preparation through a research and/or clinical doctoral degree and are ready to move quickly toward independence, rather than needing a long additional period of postdoctoral training.

What scientific or research areas does NCI emphasize for this award?

The scientific scope is broadly aligned with NCI priorities. The announcement highlights particular interest in candidates working in cancer control, cancer prevention, and cancer data sciences. These areas are especially encouraged, while the overall intent is to build a strong cohort of new independent cancer researchers supported by NCI.

Is this award only for certain cancer research topics?

No. While cancer control, cancer prevention, and cancer data sciences are specifically called out as areas of particular interest, the broader framing is to support the development of new independent investigators whose work aligns with NCI priorities.

Can the proposed project include clinical trials?

This specific funding opportunity is restricted to projects where the candidate will not lead an independent clinical trial. This includes not leading a clinical trial, not leading a clinical trial feasibility study, and not leading an ancillary clinical trial.

Can I get clinical trial experience under this award?

Yes. The NOFO allows candidates to gain clinical trial experience in a mentored context. For example, a candidate can participate in a clinical trial led by a mentor or co-mentor as part of the research and training plan, as long as the candidate is not the lead investigator.

What if I want to lead a clinical trial as part of my project?

If the candidate plans to serve as the lead investigator for a clinical trial or an ancillary clinical trial, the NOFO directs the applicant to apply to the companion opportunities PAR-23-287 or PAR-23-288, which are structured for candidates who will lead clinical trials.

What is the funding opportunity number for this announcement?

The funding opportunity number listed is PAR-23-286.

What is the CFDA number associated with this opportunity?

The CFDA number provided is 93.398.

How is this grant program categorized?

It is described as a discretionary grant program under NIH, categorized under Education and Health funding activity.

What is the original closing date for this opportunity?

The original closing date listed is 2026-10-14.

What types of organizations are eligible to apply as the applicant organization?

Eligibility for applicant organizations is broad and includes many U.S.-based entities commonly eligible for NIH grants. Examples listed include public and private institutions of higher education; state and local governments; federally recognized Native American tribal governments; tribal organizations; independent school districts; special district governments; public housing authorities/Indian housing authorities; nonprofit organizations (including 501(c)(3) and non-501(c)(3)); for-profit organizations (other than small businesses); and small businesses.

Are minority-serving institutions and other specific categories explicitly included?

Yes. The NOFO explicitly calls out additional eligible applicant categories such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, and Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).

Are faith-based or community-based organizations eligible?

Yes. Faith-based or community-based organizations are explicitly listed among eligible applicant categories.

Are federal agencies or U.S. territories included in eligibility?

Yes. The NOFO lists eligible federal agencies, regional organizations, and U.S. territories or possessions among the eligible applicant categories.

Can a foreign (non-U.S.) institution apply as the applicant organization?

No. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply as the applicant organization for this opportunity.

Can a non-domestic component of a U.S. organization apply?

No. Non-domestic components of U.S. organizations are also not eligible under this opportunity.

Is any form of international collaboration allowed?

Yes, within limits. The NOFO states that foreign components, as defined by the NIH Grants Policy Statement, are allowed. This suggests certain kinds of international collaboration or performance sites may be permissible under NIH policy, even though the primary applicant organization must be eligible and domestic.

What is the overall career impact this award is intended to have?

The award is designed to reduce the gap between postdoctoral training and independence by offering continuity of support across the career transition point from mentored postdoctoral work to an independent faculty position, helping candidates establish a stable early independent research trajectory.

What should applicants plan to do with their institutions as part of applying?

Applicants are expected to work closely with their institutions to assemble a training and transition plan that credibly positions them for an independent faculty appointment and the launch of an early independent research program.